Safety and Tolerability of Extracranial Radiation Therapy and Immune Checkpoint Inhibitors Among Patients With Metastatic Non-Small Cell Lung Cancer

被引：3
|
作者：
Ahmed, K. A. [1 ]
Creelan, B. C. [1 ]
Kim, S. [1 ]
Dilling, T. J. [1 ]
Perez, B. A. [1 ]
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2016年 / 96卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2016.06.500
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1087
引用
收藏
页码：S201 / S201
页数：1
相关论文
共 50 条
  • [1] Radiation Therapy and Checkpoint Inhibitors in Older Patients with Metastatic Non-Small Cell Lung Cancer
    Li, Y. R.
    Tran, Q. L.
    Golden, E. B.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : S225 - S226
  • [2] Safety of Palliative Radiotherapy and Immune Checkpoint Inhibitors in Patients with Metastatic Non-Small Cell Lung Cancer
    Tjong, M.
    Ragulojan, M.
    Poon, I.
    Cheng, S.
    Doherty, M.
    Ung, Y.
    Cheung, P.
    Cheema, P.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S667 - S668
  • [3] Tolerability and Safety of Thoracic Radiation and Immune Checkpoint Inhibitors Among Patients with Lung Cancer
    Ahmed, K. A.
    Grass, G. D.
    Creelan, B.
    Gray, J.
    Kim, S.
    Dilling, T. J.
    Antonia, S. J.
    Perez, B. A.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 98 (01): : 224 - 224
  • [4] Efficacy and safety of immune checkpoint inhibitors in previously treated metastatic non-small cell lung cancer
    Cunha, R.
    Fernandes, M.
    Abreu, S.
    Oliveira, C.
    Dias, J.
    Alves, S.
    Rodrigues, A.
    Oliveira, J.
    Pousa, M. I.
    Soares, M.
    Azevedo, I.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S1432 - S1432
  • [5] Sex differences in tolerability and response to immune checkpoint inhibitors in non-small cell lung cancer patients
    Duma, Narjust
    Azzouqa, Abdel-Ghani
    Yadav, Siddhartha
    Hoversten, Kahterine
    Reed, Clay
    Sitek, Andrea
    Enninga, Elizabeth
    Paludo, Jonas
    Kottschade, Lisa
    Mansfield, Aaron
    Manochakian, Rami
    Dronca, Roxana
    Adjei, Alex
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2020, 29 (06)
  • [6] Safety of current immune checkpoint inhibitors in non-small cell lung cancer
    Abdayem, Pamela
    Planchard, David
    [J]. EXPERT OPINION ON DRUG SAFETY, 2021, 20 (06) : 651 - 667
  • [7] Efficacy and safety of immune checkpoint inhibitors in non-small cell lung cancer
    Wang, Shuai
    Hao, Jiatao
    Wang, Hao
    Fang, Yong
    Tan, Lijie
    [J]. ONCOIMMUNOLOGY, 2018, 7 (08):
  • [8] Perioperative Therapy for Non-Small Cell Lung Cancer with Immune Checkpoint Inhibitors
    Soh, Junichi
    Hamada, Akira
    Fujino, Toshio
    Mitsudomi, Tetsuya
    [J]. CANCERS, 2021, 13 (16)
  • [9] Immune checkpoint inhibitors in therapy of non-small cell lung cancer (a review)
    Kolesnik, O. P.
    Mykhailychenko, V. V.
    [J]. ZAPOROZHYE MEDICAL JOURNAL, 2021, 23 (03) : 418 - 425
  • [10] Pneumonitis associated with immune checkpoint inhibitors among patients with non-small cell lung cancer
    Shannon, Vickie R.
    [J]. CURRENT OPINION IN PULMONARY MEDICINE, 2020, 26 (04) : 326 - 340
12345